Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic Dermatitis

NCT00368719 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped withdrawn due to contractual issues

Conditions

Atopic Dermatitis

Interventions

DRUG: Tacrolimus

Sponsor

University of California, Davis